Draft Patents (Amendment), Rules, 2023
The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes
Patents
-
Overview of changes to the Indian copyright law
The Copyright Amendment Act, 2012 has been enacted by the Government of India bringing changes to the Copyright Act, 1957. The amendments make Indian copyright law compliant with the Internet Treaties,
-
A broken contract
As researchers find more uses for data, informed consent has become a source of confusion. Something has to change.
-
Bayer challenges India compulsory license ruling
German pharmaceutical company Bayer AG has formally lodged a challenge against a landmark Indian ruling that allowed a domestic generic drug-maker to produce a low-cost version of an anti-cancer drug for
-
Policy reforms in the Indian pharmaceutical sector since 1994 - Impact on exports and imports
Liberalisation measures in the pharmaceutical sector have brought about major changes in the industrial licensing policy, import restrictions, foreign direct investment and production controls. It was
-
The compulsory licence for Nexavar - A landmark order
The compulsory licence issued to Natco for manufacture of the anti-cancer drug Nexavar is a landmark decision on many grounds – the first one in India since the 2005 amendment to the 1970 Patents Act and
-
Meeting the global health challenge: the role of the pharmaceutical industry
Health is a crucially important social and economic asset - a cornerstone for human development. Three of the eight Millennium Development Goals (MDGs) call for specific health improvements by 2015: reducing
-
A strike against pharma MNCs
The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. (Editorial)
-
Multinationals and monopolies - Pharmaceutical industry in India after TRIPS
In January 2005, drug product patent protection was reintroduced in India to comply with the agreement on Trade Related Aspects of Intellectual Property Rights. How are the multinational pharmaceutical
-
India grants first compulsory license to generic drug producer
In a landmark move, the Indian Patent Office announced on Monday that it has issued its first compulsory license to a domestic generic drug-maker. The decision effectively ends German pharmaceutical company
-
Govt uses special powers to slash cancer drug price
Mumbai: In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat